• Rinvoq 15 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  UPADACITINIB HEMIHYDRATE	15,4 mg

  ATC: L04A L04AF L04AF03

  Manufacturer: Abbvie Deutschland Gmbh & Co. Kg

• Rinvoq 30 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  UPADACITINIB HEMIHYDRATE	30,7 mg

  ATC: L04A L04AF L04AF03

  Manufacturer: Abbvie Deutschland Gmbh & Co. Kg

• Rinvoq 45 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  UPADACITINIB HEMIHYDRATE	46,1 mg

  ATC: L04A L04AF L04AF03

  Manufacturer: Abbvie Deutschland Gmbh & Co. Kg